Effectiveness of Oral Lactulose Versus Lactulose Enema in Hepatic Encephalopathy
Status:
Not yet recruiting
Trial end date:
2023-11-01
Target enrollment:
Participant gender:
Summary
Patients with chronic liver disease due to hepatitis B or C viruses, Non-alcoholic fatty
liver disease, autoimmune hepatitis, wilson disease, cryptogenic hepatitis etc are prone to
develop complications. Hepatic encephalopathy is one of such complications. It is graded into
four types depending on severity of clinical features, which range through altered sleep
pattern to coma. The current study aims to compare the effectiveness of lactulose enema with
oral lactulose in time to recovery from higher grade of encephalopathy to lower grade of
encephalopathy.